-
141
-
142
Network Medicine‐Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD‐L1 Expression via Targeting SPOP in Cancer
Published 2025-01-01Subjects: Get full text
Article -
143
Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors
Published 2025-02-01Subjects: Get full text
Article -
144
Subtle‐but‐smouldering myocardial injury after immune checkpoint inhibitor treatment accompanied by amyloid deposits
Published 2022-06-01Subjects: Get full text
Article -
145
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
Published 2025-02-01Subjects: Get full text
Article -
146
-
147
High and low dose radiotherapy combined with ICIs for MSS colorectal cancer patients with liver metastases: a phase I study (HaRyPOT)
Published 2025-02-01Subjects: Get full text
Article -
148
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
Published 2025-02-01Subjects: Get full text
Article -
149
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Published 2025-01-01Subjects: Get full text
Article -
150
Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer
Published 2024-11-01Subjects: Get full text
Article -
151
The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study
Published 2025-02-01Subjects: Get full text
Article -
152
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors
Published 2025-01-01Subjects: Get full text
Article -
153
Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysisResearch in context
Published 2025-03-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
154
Transformative advancements in immune checkpoint inhibitor therapy for Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Published 2024-09-01Subjects: “…Immune checkpoint inhibitor (ICI)…”
Get full text
Article -
155
A case of immune checkpoint inhibitor-related conjunctivitis controlled by tacrolimus eye drops
Published 2025-03-01Subjects: Get full text
Article -
156
Six events that shaped antibody approvals in oncology
Published 2025-02-01Subjects: Get full text
Article -
157
Electrochemical sensors for the detection of immune checkpoint related proteins and their role in cancer companion diagnostics
Published 2025-03-01Subjects: Get full text
Article -
158
Engineered ipilimumab variants that bind human and mouse CTLA-4
Published 2025-12-01Subjects: Get full text
Article -
159
Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinoma
Published 2024-12-01Subjects: Get full text
Article -
160
2’-Fucosyllactose alleviate immune checkpoint blockade-associated colitis by reshaping gut microbiota and activating AHR pathway
Published 2024-09-01Subjects: Get full text
Article